1
0
0
(1 - 24 von 34
)
Apalutamide improves OS in nonmetastatic, castration-resistant...
www.healio.com
Karim Fizazi, MD, PhD. Until recently, there were no real options for patients with castration-resistant prostate cancer. In the last 2 years, ...
Management of Prostate Cancer: A Multidisciplinary Approach - Google...
books.google.de
This book provides an exhaustive review of the current state of the art in the management of prostate cancer, from screening to treatment. A particular feature...
prostate cancer - Aiom
www.aiom.it
ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer. Presented By Karim Fizazi at Genitourinary Cancers ...
Optimal Treatment Sequence for Patients with Castration resistant...
www.youtube.com
Optimal Treatment Sequence for Patients with Castration resistant Prostate Cancer - Karim Fizazi views283 views. • Apr 2,
Final Overall Survival Analysis of the PROSPER Trial in UroTodaywww.urotoday.com › asco › video › fin...
www.urotoday.com
PROSPER study Final Overall Survival Analysis, enzalutamide in men with nonmetastatic castration resistant prostate cancer, Karim Fizazi, Alicia Morgans, ...
Developments in metastatic hormone-sensitive prostate cancer - ecancer
ecancer.org
vor 8 Tagen · Prof Karim Fizazi (Institut Gustave Roussy, Villejuif, France), Prof Neeraj Agarwal (University of Utah School of Medicine, Utah, USA), Prof Alicia ...
Custirsen shows no survival benefit in metastatic prostate cancerecancer.org › video › custirs...
ecancer.org
Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France. Prof Fizazi meets with ecancertv at ESMO to discuss the results of the AFFINITY trial of ...
Prostate Cancer Update: Prostate Cancer Update | Interview...
podcasts.apple.com
Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Karim Fizazi, MD, PhD conducted by Neil Love, MD....
Expanding horizons in metastatic prostate cancer treatment | Nature...
www.nature.com
Expanding horizons in metastatic prostate cancer treatment. Karim Fizazi &; Carsten Goessl. Nature Reviews Clinical Oncology volume 8, ...
Karim Fizazi on Prostate Cancer Abiraterone Acetate, Prednisone ...mashupmd.com › karim-fizazi-on-prostate-cancer-a...
mashupmd.com
vor 7 Tagen · Karim Fizazi, MD, PhD, on Prostate Cancer: Abiraterone Acetate, Prednisone, and Radiotherapy in Metastatic Disease https://t.co/lEWsiXTQX3 ...
Karim Fizazi, MD, PhD, on the ARAMIS Trial in Prostate Cancer ...ascopost.com › videos › asco-annual-meeting
ascopost.com
Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, University of Paris-Sud, discusses study findings showing that not only does darolutamide prolong ...
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen Semantic Scholarwww.semanticscholar.org › paper
www.semanticscholar.org
Semantic Scholar extracted view of "Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer.
Karim Fizazi, Autor auf streamedup!
www.streamed-up.com
Karim Fizazi. Videos. Keine Ergebnisse. Prostate Cancer · Karim Fizazi Über streamedup! Kontakt · AGB · Impressum · Datenschutz.
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing...
pubmed.ncbi.nlm.nih.gov
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:
Research To Practice | Oncology Videos: Prostate Cancer | Karim...
videopodcast.researchtopractice.com
Prostate Cancer Update, Issue 1, — Part 2: Our interview with Dr Fizazi highlights the following topics as well as cases from his practice: ...
The Impact of Taxotere on Adjuvant Breast Cancer - PDF Free Download
docplayer.net
Karim Fizazi, MD, PhD Institut Gustave Roussy Villejuif, France. Should we use Docetaxel in hormone- naïve prostate cancer? Karim Fizazi, MD, PhD Institut Gustave ...
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic ...mashupmd.com › cabazitaxel-vers...
mashupmd.com
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Castration-Resistant Prostate Cancer – Karim Fizazi. Mashup Score: 0. UroToday - In the CARD ...
Search - MEDtalkswww.medtalks.nl › search
www.medtalks.nl
Karim Fizazi, MD, PhD has collaborated on the following programs: Quarterly Focus on Genitourinary Cancer: highlights in prostate cancer (part 2). Niven Mehra ...
Metastatic Hormone-Sensitive Prostate Cancer: Clinical ...jhu.pure.elsevier.com › publications › metastatic-...
jhu.pure.elsevier.com
David J. VanderWeele, Emmanuel S. Antonarakis, Michael A. Carducci, Robert Dreicer, Karim Fizazi, Silke Gillessen, Celeste S. Higano, Alicia ...
New Standard for Metastatic Castration-Sensitive Prostate Cancer ...www.medpagetoday.com › ... › ASCO
www.medpagetoday.com
vor 6 Tagen · ... therapy (ADT) and docetaxel extended rPFS by a median 2.5 years for these patients, and could be practice changing, reported Karim Fizazi, ...
Olaparib for Metastatic Castration-Resistant Prostate Cancer.findanexpert.unimelb.edu.au › Scholarlywork
findanexpert.unimelb.edu.au
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine ...
Prostate Cancer Update, Issue 1, (Audio Program) | Research To...
www.researchtopractice.com
... Cancer Update, Issue 1, (Audio Program). Released March Featuring perspectives from Drs Maha Hussain and Karim Fizazi. (Audio Program).
Update on Systemic Prostate Cancer Therapies: Management of...
jhu.pure.elsevier.com
Philipp Nuhn, Johann S. De Bono, Karim Fizazi, Stephen J. Freedland, Maurizio Grilli, Philip W. Kantoff, Guru Sonpavde, Cora N. Sternberg, ...
Alle Infos zum Namen "Karim Fizazi"
Verwandte Suchanfragen zu Karim Fizazi
| Alicia Morgans Silke Gillessen Lothar Kanz |
Personen Vorname "Karim" (3666) Name "Fizazi" (12) |
sortiert nach Relevanz / Datum